Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation

Study Questions:

How does the use of a left atrial appendage (LAA) occlusion device instead of warfarin for stroke prevention in patients with atrial fibrillation (AF) affect quality of life (QOL)?